16th Annual Scientific Meeting - Heart Failure Society of America

Sept. 11
Tuesday
AM
oral abstract session
Tuesday, September 11
8:30-10:00 AM
Meeting Room 612
POSTERS DISPLAYED
Tuesday, September 11
9:30 AM-7:00 PM
Exhibit Hall 4B
Sept. 11
Tuesday
AM
Tuesday
Featured Oral Abstract Session
Moderators: Lynne V. Doering, Los Angeles, CA
Javed Butler, Atlanta, GA
8:30* Randomized Controlled Trial of a Biobehavioral 221
Intervention for Depression in Patients with
Heart Failure
Debra K. Moser, Jia-Rong Wu, Misook L. Chung, Martha
J. Biddle, Mary Schooler, Terry A. Lennie; College of
Nursing, University of Kentucky, Lexington, KY; College
of Nursing, University of North Carolina-Chapel Hill, NC
8:45* Marked Changes in Right Marked Changes in 022
Right after Cardiac Surgery May Be Secondary
to Pericardial Incision: Implications for the Post-
Surgical Assessment of Right Ventricular Function
Amresh Raina, Anjali V. Fields, Susan Chambers, Zachary
M. Gertz, Paul R. Forfia; Cardiovascular Institute,
Allegheny General Hospital, Pittsburgh, PA; Cardiovascular
Division, Hospital of the University of Pennsylvania,
Philadelphia, PA
9:00* Metformin, but Not Diet-Induced Weight Loss, 017
Decreases Myocardial Fibrosis in a Murine Model
of Diet-Induced Insulin Resistance and
Cardiomyopathy
Tomasz Wietecha, Jinkyu Kim, Antonio Sta Teresa, Kelly
Hudkins, Charles E. Alpers, Kevin D. O’Brien; Medicine
(Cardiology), University of Washington, Seattle, WA;
Pathology, University of Washington, Seattle, WA
9:15* Algisyl-LVR Reduces Left Ventricular Wall 183
Stress and Improves Function in the Failing
Human Heart
Lik Chuan Lee, Doron Klepach, Andy Hinson, Randall
Lee, Julius Guccione; UCSF, San Francisco, CA; LoneStar
Heart, Inc., Laguna Hills, CA
9:30* Cardiac Specific Gene Delivery of a Dual 076
GC-A and GC-B Agonist, CD-NP, Mediates Anti-
Hypertrophic Actions in a Model of Hypertensive
Heart Disease beyond GC-A Activation Alone Via BNP
Alessandro Cataliotti, Jason M. Tonne, Sarah Mangiafico,
John C. Burnett, Jr., Yasuhiro Ikeda; Cardiorenal Research
Laboratory, Mayo Clinic, Rochester, MN; Molecular
Medicine, Mayo Clinic, Rochester, MN
9:45* Discordance between Peak Metabolic Demand 114
and LVAD Flow Rate during Upright
Symptom-Limited Exercise
Dennis J. Kerrigan, Celeste T. Williams, Jonathan K.
Ehrman, Matthew A. Saval, Kyle Bronsteen, John R.
Schairer, Cheryl Smith, Steven J. Keteyian; Division of
Cardiovascular Medicine, Henry Ford Hospital, Detroit, MI
*15 minutes each (10 minute presentation, 5 minutes
discussion)
Learning Objective: Discuss findings from recent
research in heart failure and their implications for heart
failure research and treatment.
PRESENTERS AT POSTERS 5:45 PM-6:45 PM
Categories Poster #
Cardiovascular Physiology 016, 018, 024, 026, 039-061
Cardiovascular Structure 069-075
Neurohormones/Cytokines 082, 086-095
Molecular Biology and Genetics 104-111
VADs/transplant/surgery 134-154
Electrophysiology and rhythm devices 157, 168-181
Clinical Trials 184, 189-197
Cardiovascular Pharmacology 204-208
Epidemiology, Prevention 215-220
Outcomes 226, 230, 255-287
Clinical Care/ 288, 290-297, 299-322
Management Strategies
Listing for Monday posters begins on page 62
Listing for Tuesday posters begins on page 115
Tuesday
10:00 Coffee Break
Refreshments served in Exhibit Hall 4B
10:00 Coffee Break
Refreshments served in Exhibit Hall 4B
96 97